HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 2,597: Line 2,597:


Andrew Siref, MD
Andrew Siref, MD
|4/12/2024
|10/14/2025
| ||Pending
| ||Pending
| ||SK|| ||
| ||SK|| ||
Line 2,662: Line 2,662:


Andrew Siref, MD
Andrew Siref, MD
|4/12/2024|| ||Pending
|10/14/2025|| ||Pending
| ||SK|| ||
| ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
Line 2,710: Line 2,710:
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  
Andrew Siref, MD
Andrew Siref, MD
|3/20/2024
|10/14/2025
| ||Pending|| ||SK|| ||
| ||Pending|| ||SK|| ||
|Enteropathy-Associated T-cell Lymphoma
|Enteropathy-Associated T-cell Lymphoma
Line 2,720: Line 2,720:
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  
Andrew Siref, MD
Andrew Siref, MD
|3/20/2024
|10/14/2025
| ||Pending|| ||SK|| ||
| ||Pending|| ||SK|| ||
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Line 2,833: Line 2,833:
|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);
|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);
Andrew Siref, MD
Andrew Siref, MD
|3/22/2024|| ||Pending|| ||SK|| ||
|10/14/2025|| ||Pending|| ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)